Free Trial

The 10 Best Lithium Stocks to Buy for a Post Gasoline World - 8 of 10

 
 

Albemarle (NYSE:ALB)

Consensus Rating
Hold
Rating Score
2.3
Ratings Breakdown
7 Buy Ratings, 15 Hold Ratings, 1 Sell Ratings.
Consensus Price Target
$117.10 (21.9% Upside)

About Albemarle

Albemarle logoAlbemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
8/28/2024Evercore ISILower Price TargetOutperform ➝ Outperform$190.00 ➝ $170.00
8/19/2024JPMorgan Chase & Co.Lower Price TargetNeutral ➝ Neutral$115.00 ➝ $78.00
8/16/2024Deutsche Bank AktiengesellschaftLower Price TargetHold ➝ Hold$105.00 ➝ $80.00
8/8/2024Piper SandlerLower Price TargetUnderweight ➝ Underweight$95.00 ➝ $90.00
8/6/2024ScotiabankLower Price TargetSector Perform ➝ Sector Perform$135.00 ➝ $85.00
8/6/2024Royal Bank of CanadaLower Price TargetOutperform ➝ Outperform$128.00 ➝ $111.00
8/5/2024Baird R WDowngradeStrong-Buy ➝ Hold
8/5/2024KeyCorpLower Price TargetOverweight ➝ Overweight$151.00 ➝ $132.00
8/5/2024Robert W. BairdDowngradeOutperform ➝ Neutral$102.00 ➝ $85.00
8/2/2024Bank of AmericaLower Price TargetBuy ➝ Buy$135.00 ➝ $126.00
 

FDA’s hidden signal greenlights biotech winners — 97% of the time (Ad)

The FDA has started to quietly send out a signal … That has given investors a 97% chance of making money. Perhaps as soon as 9:30 a.m. tomorrow.

Click here to find out how you can get in before the FDA’s potential signal.